Catalyst Wire Dossier Catalyst Wire Dossier

Rencarex®

· Heidelberg Pharma AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rencarex®, covering 2018-09-12 to 2018-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer [Phase 3]

See pricing